{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T12:50:50Z","timestamp":1693745450630},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s11926-009-0027-z","type":"journal-article","created":{"date-parts":[[2009,7,20]],"date-time":"2009-07-20T10:58:49Z","timestamp":1248087529000},"page":"196-201","source":"Crossref","is-referenced-by-count":11,"title":["Denosumab for joints and bones"],"prefix":"10.1007","volume":"11","author":[{"given":"E. Michael","family":"Lewiecki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,21]]},"reference":[{"key":"27_CR1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.18.2323","volume":"285","author":"A. Klibanski","year":"2001","unstructured":"Klibanski A, Adams-Campbell L, Bassford T, et al.: Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285:785\u2013795.","journal-title":"JAMA"},{"key":"27_CR2","volume-title":"Bone Health and Osteoporosis: A Report of the Surgeon General","author":"US Department of HealthHuman Services","year":"2004","unstructured":"US Department of Health and Human Services: Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of the Surgeon General; 2004."},{"key":"27_CR3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","volume":"22","author":"R. Burge","year":"2007","unstructured":"Burge R, Dawson-Hughes B, Solomon DH, et al.: Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025. J Bone Miner Res 2007, 22:465\u2013475.","journal-title":"J Bone Miner Res"},{"key":"27_CR4","unstructured":"International Osteoporosis Foundation: IOF Osteoporosis Teaching Slide Kit. Available at http:\/\/www.osteofound.org\/health_professionals\/teaching_resources\/slide_kit.html . Accessed March 2006."},{"issue":"Suppl1","key":"27_CR5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000063449","volume":"54","author":"E. Dennison","year":"2000","unstructured":"Dennison E, Cooper C: Epidemiology of osteoporotic fractures. Horm Res 2000, 54(Suppl 1):58\u201363.","journal-title":"Horm Res"},{"issue":"2A","key":"27_CR6","doi-asserted-by":"crossref","first-page":"12S","DOI":"10.1016\/S0002-9343(97)90022-X","volume":"103","author":"C. Cooper","year":"1997","unstructured":"Cooper C: The crippling consequences of fractures and their impact on quality of life. Am J Med 1997, 103(2A):12S\u201319S.","journal-title":"Am J Med"},{"key":"27_CR7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.0105-2896.2005.00338.x","volume":"208","author":"N.C. Walsh","year":"2005","unstructured":"Walsh NC, Crotti TN, Goldring SR, Gravallese EM: Rheumatic diseases: the effects of inflammation on bone. Immunol Rev 2005, 208:228\u2013251.","journal-title":"Immunol Rev"},{"key":"27_CR8","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.berh.2007.05.005","volume":"21","author":"A. Kavanaugh","year":"2007","unstructured":"Kavanaugh A: Economic consequences of established rheumatoid arthritis and its treatment. Best Pract Res Clin Rheumatol 2007, 21:929\u2013942.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"27_CR9","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","volume":"19","author":"P.J. Bekker","year":"2004","unstructured":"Bekker PJ, Holloway DL, Rasmussen AS, et al.: A singledose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res 2004, 19:1059\u20131066.","journal-title":"J Bone Miner Res"},{"key":"27_CR10","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.RES.0000149165.99974.12","volume":"95","author":"P. Collin-Osdoby","year":"2004","unstructured":"Collin-Osdoby P: Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 2004, 95:1046\u20131057.","journal-title":"Circ Res"},{"key":"27_CR11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"W.S. Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, et al.: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997, 89:309\u2013319.","journal-title":"Cell"},{"key":"27_CR12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.292.4.490","volume":"292","author":"L.C. Hofbauer","year":"2004","unstructured":"Hofbauer LC, Schoppet M: Clinical implications of the osteoprotegerin\/RANKL\/RANK system for bone and vascular diseases. JAMA 2004, 292:490\u2013495.","journal-title":"JAMA"},{"key":"27_CR13","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1359\/jbmr.2001.16.2.348","volume":"16","author":"P.J. Bekker","year":"2001","unstructured":"Bekker PJ, Holloway D, Nakanishi A, et al.: The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 2001, 16:348\u2013360.","journal-title":"J Bone Miner Res"},{"key":"27_CR14","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/jps.20178","volume":"93","author":"E.D. Lobo","year":"2004","unstructured":"Lobo ED, Hansen RJ, Balthasar JP: Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci 2004, 93:2645\u20132668.","journal-title":"J Pharm Sci"},{"key":"27_CR15","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/jps.20125","volume":"93","author":"L. Tang","year":"2004","unstructured":"Tang L, Persky AM, Hochhaus G, Meibohm B: Pharmacokinetic aspects of biotechnology products. J Pharm Sci 2004, 93:2184\u20132204.","journal-title":"J Pharm Sci"},{"issue":"Suppl1","key":"27_CR16","first-page":"S293","volume":"20","author":"M.C. Peterson","year":"2005","unstructured":"Peterson MC, Stouch BJ, Martin SW, et al.: The pharmacokinetics of denosumab (AMG 162) following various multiple subcutaneous dosing regimens in postmenopausal women with low bone mass. J Bone Miner Res 2005, 20(Suppl 1):S293.","journal-title":"J Bone Miner Res"},{"key":"27_CR17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","volume":"354","author":"M.R. McClung","year":"2006","unstructured":"McClung MR, Lewiecki EM, Cohen SB, et al.: Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 2006, 354:821\u2013831.","journal-title":"N Engl J Med"},{"key":"27_CR18","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1359\/jbmr.070809","volume":"22","author":"E.M. Lewiecki","year":"2007","unstructured":"Lewiecki EM, Miller PD, McClung MR, et al.: Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low bone mineral density. J Bone Miner Res 2007, 22:1832\u20131841.","journal-title":"J Bone Miner Res"},{"key":"27_CR19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","volume":"43","author":"P.D. Miller","year":"2008","unstructured":"Miller PD, Bolognese MA, Lewiecki EM, et al.: Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial. Bone 2008, 43:222\u2013229.","journal-title":"Bone"},{"key":"27_CR20","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-2814","volume":"93","author":"H.G. Bone","year":"2008","unstructured":"Bone HG, Bolognese MA, Yuen CK, et al.: Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. J Clin Endocrinol Metab 2008, 93:2149\u20132157.","journal-title":"J Clin Endocrinol Metab"},{"key":"27_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1359\/jbmr.0809010","volume":"24","author":"J.P. Brown","year":"2009","unstructured":"Brown JP, Prince RL, Deal C, et al.: Comparison of the effect of denosumab and alendronate on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res 2009, 24:153\u2013161.","journal-title":"J Bone Miner Res"},{"key":"27_CR22","unstructured":"Kendler DL, Benhamou CL, Brown JP, et al.: Effects of denosumab vs alendronate on bone mineral density (BMD), bone turnover markers (BTM), and safety in women previously treated with alendronate. J Bone Miner Res 2008, S473."},{"issue":"Suppl1","key":"27_CR23","first-page":"S80","volume":"23","author":"S.R. Cummings","year":"2008","unstructured":"Cummings SR, McClung MR, Christiansen C, et al.: A phase III study of the effects of denosumab on vertebral, nonvertebral, and hip fracture in women with osteoporosis: results from the FREEDOM trial. J Bone Miner Res 2008, 23(Suppl 1):S80.","journal-title":"J Bone Miner Res"},{"key":"27_CR24","unstructured":"Amgen Inc: Form 8-K. Available at http:\/\/investors.amgen.com\/phoenix.zhtml?c=61656&p=irol-sec . Accessed September 2008."},{"key":"27_CR25","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","volume":"58","author":"S.B. Cohen","year":"2008","unstructured":"Cohen SB, Dore RK, Lane NE, et al.: Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum 2008, 58:1299\u20131309.","journal-title":"Arthritis Rheum"},{"key":"27_CR26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"F.C. Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315\u2013324.","journal-title":"Arthritis Rheum"},{"key":"27_CR27","first-page":"1387","volume":"30","author":"F. McQueen","year":"2003","unstructured":"McQueen F, Lassere M, Edmonds J, et al.: OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Summary of OMERACT 6 MR Imaging Module. J Rheumatol 2003, 30:1387\u20131392.","journal-title":"J Rheumatol"},{"key":"27_CR28","first-page":"261","volume":"27","author":"D. Heijde van der","year":"2000","unstructured":"van der Heijde D: How to read radiographs according to the Sharp\/van der Heijde method. J Rheumatol 2000, 27:261\u2013263.","journal-title":"J Rheumatol"},{"issue":"Suppl1","key":"27_CR29","first-page":"S295","volume":"20","author":"S.B. Cohen","year":"2005","unstructured":"Cohen SB, Lewiecki EM, Liu Y, et al.: Phase 2 study of denosumab (AMG 162) in postmenopausal women: subanalyses and supplemental safety. J Bone Miner Res 2005, 20(Suppl 1):S295.","journal-title":"J Bone Miner Res"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-009-0027-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-009-0027-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-009-0027-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:49:51Z","timestamp":1559436591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-009-0027-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1007\/s11926-009-0027-z","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}